At the time of writing, Milestone Pharmaceuticals Inc [MIST] stock is trading at $2.02, up 3.06%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MIST shares have gain 3.59% over the last week, with a monthly amount drifted -24.91%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Milestone Pharmaceuticals Inc [NASDAQ: MIST] stock has seen the most recent analyst activity on December 15, 2025, when TD Cowen upgraded its rating to a Buy but kept the price target unchanged to $8 for it. Previously, Wells Fargo started tracking the stock with Overweight rating on September 11, 2025, and set its price target to $4. Rodman & Renshaw started tracking the stock assigning a Buy rating and suggested a price target of $9 on August 22, 2024. Jefferies downgraded its rating to a Hold and reduced its price target to $4 on June 20, 2023. Piper Sandler upgraded its rating to Overweight for this stock on April 22, 2022, and upped its price target to $10. In a note dated March 05, 2021, H.C. Wainwright initiated a Buy rating and provided a target price of $20 on this stock.
For the past year, the stock price of Milestone Pharmaceuticals Inc fluctuated between $0.63 and $3.06. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Milestone Pharmaceuticals Inc [NASDAQ: MIST] shares were valued at $2.02 at the most recent close of the market. An investor can expect a potential return of 296.04% based on the average MIST price forecast.
Analyzing the MIST fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.66, Equity is -23.73 and Total Capital is -0.74. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.79.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.97 points at the first support level, and at 1.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.06, and for the 2nd resistance point, it is at 2.10.
Ratios To Look Out For
It is important to note that Milestone Pharmaceuticals Inc [NASDAQ:MIST] has a current ratio of 8.24. As well, the Quick Ratio is 8.24, while the Cash Ratio is 4.44.
